日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/C.

Methylstat 通过靶向组蛋白去甲基化酶 JMJD1B/C 使卵巢癌细胞对 PARP 抑制剂敏感

Schwarz Franziska Maria, Klotz Daniel Martin, Yang Ruming, Brux Melanie, Buchholz Frank, Harb Hani, Link Theresa, Wimberger Pauline, Theis Mirko, Kuhlmann Jan Dominik

Research progress on immunotherapy in triple‑negative breast cancer (Review)

三阴性乳腺癌免疫治疗的研究进展(综述)

Zhang, Xiaoxiao; Ge, Xueying; Jiang, Tinghan; Yang, Ruming; Li, Sijie